ArticlebioRxiv : the preprint server for biology2026
Sotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM Mice.
Keith Saum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.